Granulocyte-Macrophage Colony-Stimulating Factor Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Also known as: CSF, CSF2, Colony Stimulating Factor 2, Colony Stimulating Factor, Granulocyte-Macrophage, Colony-Stimulating Factor +7 more

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

Zhongnan Hospital1
Mayo Clinic1

Indications

Cancer2
Breast Ductal Carcinoma In Situ1
Cervical Cancer1
Breast Cancer1

Other1 trial

Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

Phase 2

Jacksonville, Florida1 trial

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic in Florida

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.